Hannah Billson is a life sciences associate advising clients on regulatory matters and English and EU litigation.
Ms. Billson has experience advising and representing clients on high profile topical issues such as the transparency of clinical trial data. She also regularly advises on marketing authorisations for medicines; CE marking of medical devices; borderline determinations; clinical trials; interactions with HCPs and advertising. On the commercial side, Ms. Billson has assisted with regulatory due diligence on a number of corporate/commercial transactions.
Ms. Billson has advised leading pharmaceutical, biotechnology, medical device, cosmetic and food companies.